What Is Ocular Therapeutix, Inc. (OCUL) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Ocular Therapeutix, Inc.'s intrinsic value is estimated at $4.37, suggesting the stock is overvalued at its current price of $9.70. With 10 out of 11 models flagging downside (-54.9% average return), the market may be pricing in unsustainable growth. Notably, PWERM sees the most upside at -1.8% (fair value: $9.53), while ML-RIV is the most conservative at -98.9% ($0.11). The spread between these extremes — +97.1% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About OCUL?
11 of 13 models are currently active for OCUL. All 11 active models suggest the stock trades above fair value. The Bayesian DCF estimates OCUL's intrinsic value at $4.68, implying -51.7% downside from the current price. See which stocks rank higher →
How Does OCUL Rank in Pharmaceutical Preparations?
Among 469 Pharmaceutical Preparations stocks, OCUL ranks #50 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, Ocular Therapeutix, Inc. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating OCUL should weigh these sector-specific dynamics alongside our model-derived fair values.
Is OCUL a Value Trap?
CirclFi's Value Trap algorithm assigns OCUL a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Ocular Therapeutix, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Ocular Therapeutix, Inc.'s fundamental quality profile registers 7.4/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +97.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every OCUL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across OCUL's 11 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad